In Australia, heart failure affects over half a million individuals, making up over 150,000 hospitalisations per year, over 60,000 deaths, and a cost of over $3 billion. Globally, heart failure affects more than 60 million people and is the world’s leading cause of hospitalisation in people over 65 years. It makes up 17% of all
Read More
Hospital care in the United States is set for greater digitisation with hospital services provided Inova Health expanding their Master Services Agreement with medtech company OneView Healthcare (ASX: ONE). Through the increasing transition towards digitisation of hospital services, gone are the nights of having nurses walk in and out of the room frequently throughout the
Read More
Aussie biosensor company Universal Biosensors (ASX: UBI) has received the US FDA 510(k) and CLIA Waiver approval for its Xprecia Prime Coagulation Analyzer as a Class II device. Xprecia Prime is a portable coagulation monitoring device that provides fast and accurate PT/INR testing (measuring how long it takes for blood to clot) specifically for patients
Read More
In the world of science, getting accurate and consistent results is key. Thanks to artificial intelligence and automation advancements, achieving this is now easier than ever. Take, for example, the APAS® PharmaQC product from Australian MedTech company LBT Innovations (ASX: LBT). Using AI technology, microbiologists can analyse multiple culture plates. By removing the variability often
Read More
Medical device company Atomo Diagnostics (ASX: AT1) has locked in purchase orders from Viatris Healthcare Pty Ltd amounting to approximately $970,000 for HIV Self-Tests. These tests, manufactured by Atomo under the Mylan brand, are designated for supply to several Low- and Middle-Income Countries (LMICs). The orders are scheduled for production during the second half of
Read More
Sydney-based MedTech company Next Science (ASX: NXS) has reported a bumper result with its annual sales, reaching $33.7 million, a 90% increase compared to the previous year. This surge is primarily attributed to the expansion in the Wound Care and Surgical segments, driven by a strategic focus on direct sales and the successful implementation of
Read More